Stock PPCB PROPANC BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Propanc Biopharma, Inc.

Equities

PPCB

US74346N6022

Market Closed - OTC Markets
Other stock markets
 15:45:20 2024-05-17 EDT 		5-day change 1st Jan Change
0.0007 USD 0.00% Intraday chart for Propanc Biopharma, Inc. -30.00% -94.17%
04-16 Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office CI
04-16 Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Carlo Campiciano Resigns as Chief Financial Officer of Propanc Biopharma, Inc
CI
Propanc Biopharma, Inc. Announces Executive Changes
CI
Propanc Biopharma, Inc. and Propanc Pty Ltd Announce Management Appointments, Effective July 1, 2019
CI
Propanc Biopharma Appoints Ralf Brandt to Scientific Advisory Board
CI
Propanc Biopharma Inc. Announces the Engagement of Mr. Alan Morell as A Senior Strategic Advisor for the Company
CI
Propanc Health Group Corporation will Change its Name to Propanc Biopharma Inc
CI
Propanc Health Group Corporation Announces the Resignation of Douglas Mitchell as President and Chairman of Board of Director of Company
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PPCB Stock
  4. News Propanc Biopharma, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW